Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors

This publication has 11 references indexed in Scilit:

• Conformational analysis of the dopamine-receptor agonist 5-hydroxy-2-(dipropylamino)tetralin and its C(2)-methyl-substituted derivative
  Journal of Medicinal Chemistry, 1986
• The 5-HT Syndrome and the Drug Discrimination Paradigm in Rats:Application in Behavioral Studies on the Central 5-HT System
  Pharmacopsychiatry, 1985
• Receptor-mediated Regulation of 5-Hydroxytryptamine Metabolism:Current Knowledge and Open Questions
  Pharmacopsychiatry, 1985
• 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists
  Journal of Medicinal Chemistry, 1984
• 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site
  European Journal of Pharmacology, 1983
• 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
• 8-Hydroxy-2-(dipropylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist
  Journal of Medicinal Chemistry, 1981
• An animal behavior model for studying central serotonergic synapses
  Life Sciences, 1976
• Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in Vivo using an inhibitor of the aromatic amino acid decarboxylase
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1972
• α‐Substituierte Dopacetamide als Hemmer der Catechol‐O‐methyl‐transferase und der enzymatischen. Hydroxylierung aromatischer Aminosäuren. In den Catecholamin‐Metabolismus eingreifende Substanzen. 2. Mitteilung
  Helvetica Chimica Acta, 1963